These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


126 related items for PubMed ID: 4659043

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Lymphocyte mediated cytotoxicity to tumor antigens.
    Hellström I, Hellström KE.
    Johns Hopkins Med J Suppl; 1974; 3():37-50. PubMed ID: 4608238
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cell-mediated immune mechanisms of tumor cell destruction.
    Perlmann P, O'Toole C, Unsgaard B.
    Fed Proc; 1973 Feb; 32(2):153-5. PubMed ID: 4540104
    [No Abstract] [Full Text] [Related]

  • 8. Specificity of in vitro cellular cytotoxicity against transitional cell carcinoma cell line T-24.
    Catalona WJ, Oldham RK, Djeu JY, Herberman RB, Cannon GB.
    Surg Forum; 1975 Feb; 26():122-4. PubMed ID: 56048
    [No Abstract] [Full Text] [Related]

  • 9. Standardization of microcytotoxicity assay for cell-mediated immunity.
    O'Toole C.
    Natl Cancer Inst Monogr; 1973 Jun; 37():19-24. PubMed ID: 4713781
    [No Abstract] [Full Text] [Related]

  • 10. Studies on specificity of cell-mediated immunity to human tumors.
    Takasugi M, Mickey MR, Terasaki PI.
    J Natl Cancer Inst; 1974 Dec; 53(6):1527-38. PubMed ID: 4140237
    [No Abstract] [Full Text] [Related]

  • 11. Cellular immunity and blocking antibodies to tumors.
    Hellström I, Hellström KE.
    J Reticuloendothel Soc; 1971 Jul; 10(1):131-6. PubMed ID: 5121177
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cell-mediated cytotoxicity for bladder carcinoma: evaluation of a workshop.
    Bean MA, Bloom BR, Herberman RB, Old LJ, Oettgen HF, Klein G, Terry WD.
    Cancer Res; 1975 Oct; 35(10):2902-13. PubMed ID: 1157057
    [No Abstract] [Full Text] [Related]

  • 15. Assessment of cell-mediated immunity to human tumor-associated antigens.
    Baldwin RW, Embeton MJ.
    Int Rev Exp Pathol; 1977 Oct; 17():49-95. PubMed ID: 849883
    [No Abstract] [Full Text] [Related]

  • 16. Transplantation immunity to individually unique antigens of chemically induced bladder tumors in mice.
    Wahl DV, Chapman WH, Hellström I, Hellström KE.
    Int J Cancer; 1974 Jul 15; 14(1):114-21. PubMed ID: 4142461
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Lymph node reactivity to experimental bladder tumor in preimmunized animals as measured by two parameter flow cytometry.
    Collste LG, Kostyrka-Claps ML, Darzynkiewicz Z, Devonec M, Traganos F, Whitmore WF, Melamed MR.
    Invest Urol; 1979 Nov 15; 17(3):191-4. PubMed ID: 500314
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.